The Europe Optical Coherence Tomography (OCT) Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
OCT technology has advanced significantly as well. At acquisition rates of many frames per second, high-speed real-time optical coherence tomography imaging has been demonstrated. Axial resolutions of as much as 1 micrometer have been reached in ultrahigh-resolution and high-resolution OCT imaging experiments employing new laser light sources. Recently, developmental biology samples showed evidence of cellular-level OCT imaging. In order to provide inside-body imaging, OCT has been interconnected with endoscopes, catheters, and laparoscopes.
It has been shown in vivo in an animal model that artery imaging is possible with endoscope and catheter OCT imaging of the pulmonary, gastrointestinal, and urine systems. In addition, there have been reports of early endoscopic OCT experiments in humans. There are numerous research teams conducting preliminary clinical investigations right now.
The market for optical coherence tomography is expected to increase as more OCT products are introduced and more major companies worldwide invest in improved OCT production. In addition, more hospitals and clinics are utilizing optical coherence tomography (OCT), which is likely to drive the OCT market's expansion due to the higher accuracy of the data obtained.
The incidence of eye illnesses is rising, medical tourism is expanding, and research and development spending is rising. Due to increased occurrences of eye disorders, cancer, and many cardiovascular diseases, healthcare spending has dramatically increased recently throughout the region. The Office for National Statistics estimates that in 2019, overall healthcare spending increased to reach over 225 billion. Also, the rapid growth of the optical imaging industry in the UK, combined with an increase in ophthalmology clinics, is anticipated to generate profitable growth possibilities for the producers of optical coherence tomography systems. Hence, thereby boosting the market growth in Europe.
The Germany market dominated the Europe Optical Coherence Tomography (OCT) Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $136.1 million by 2028. The UK market is anticipated to grow at a CAGR of 7.6% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9.3% during (2022 - 2028).
Based on Type, the market is segmented into Handheld OCT Devices, Tabletop OCT Devices, and Catheter-based OCT. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Application, the market is segmented into Ophthalmology, Cardiovascular, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Optical Coherence Tomography (OCT) Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 8.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Carl Zeiss AG, Danaher Corporation, Metall Zug AG (Haag-Streit AG), Nidek Co., Ltd., Thorlabs, Inc., Topcon Corporation, Agfa-Gevaert N.V. (IG arben), Heidelberg Engineering, Inc. (Heidelburg Engeneering GmbH), and Novacam Technologies Inc.
By Type
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
